Ternary Cu
2
SnS
3
(CTS) is an attractive nontoxic
and earth-abundant absorber material with suitable optoelectronic
properties for cost-effective photoelectrochemical applications. Herein,
we report the synthesis of high-quality CTS nanoparticles (NPs) using
a low-cost facile hot injection route, which is a very simple and
nontoxic synthesis method. The structural, morphological, optoelectronic,
and photoelectrochemical (PEC) properties and heterojunction band
alignment of the as-synthesized CTS NPs have been systematically characterized
using various state-of-the-art experimental techniques and atomistic
first-principles density functional theory (DFT) calculations. The
phase-pure CTS NPs confirmed by X-ray diffraction (XRD) and Raman
spectroscopy analyses have an optical band gap of 1.1 eV and exhibit
a random distribution of uniform spherical particles with size of
approximately 15–25 nm as determined from high-resolution transmission
electron microscopy (HR-TEM) images. The CTS photocathode exhibits
excellent photoelectrochemical properties with PCE of 0.55% (fill
factor (FF) = 0.26 and open circuit voltage (Voc) = 0.54 V) and photocurrent
density of −3.95 mA/cm
2
under AM 1.5 illumination
(100 mW/cm
2
). Additionally, the PEC activities of CdS and
ZnS NPs are investigated as possible photoanodes to create a heterojunction
with CTS to enhance the PEC activity. CdS is demonstrated to exhibit
a higher current density than ZnS, indicating that it is a better
photoanode material to form a heterojunction with CTS. Consistently,
we predict a staggered type-II band alignment at the CTS/CdS interface
with a small conduction band offset (CBO) of 0.08 eV compared to a
straddling type-I band alignment at the CTS/ZnS interface with a CBO
of 0.29 eV. The observed small CBO at the type-II band aligned CTS/CdS
interface points to efficient charge carrier separation and transport
across the interface, which are necessary to achieve enhanced PEC
activity. The facile CTS synthesis, PEC measurements, and heterojunction
band alignment results provide a promising approach for fabricating
next-generation Cu-based light-absorbing materials for efficient photoelectrochemical
applications.
Inorganic metal halide perovskites CsPbX3 (X = Cl, Br, and I) has achieved extensive attention in recent years for photovoltaics because of their unique properties like tunable band gap, high charge carrier mobility, high absorption coefficient, etc. and which makes it suitable for optoelectronic applications. In this work, we have reported a facile synthesis method of inorganic CsPbBr3 nanoparticles (NPs) at room temperature using cesium bromide (CsBr) as a Cs source, lead bromide (PbBr2) as Br source, oleic acid, and Oleylamine as capping ligands. Nucleation starts immediately after the injection of a precursor solution into the toluene. Synthesis of CsPbBr3 NPs was confirmed by X-Ray diffraction pattern, UV-Visible spectroscopy, photoluminescence (PL), scanning electron microscopy (SEM), and atomic force microscopy (AFM). X-ray diffraction pattern reveals mainly the monoclinic crystal structure of CsPbBr3 NPs. The UV-Vis absorption spectra and PL spectra show a strong absorption peak at 509 nm, emission peak at 505 nm, and the band gap of CsPbBr3 to be 2.2 eV. The synthesized CsPbBr3 exhibit regular cuboid like structure with a particle size of approximately 400-500 nm. The surface roughness morphology of CsPbBr3 NPs was studied using AFM, and it shows the roughness of the CsPbBr3 films was around 260 nm. These results provide a facile synthesis method, and CsPbBr3 NPs are a suitable candidate for the optoelectronic and photovoltaic device's application.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.